Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Tipranavir/Ritonavir in HIV-1 Infected Patients
NCT00146328Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2001
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started Apr 2001; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00146328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146328.